Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinoma

Macrophage Colony ◽

PImmunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2

Oncology Reports ◽

10.3892/or.13.4.751 ◽

2005 ◽

Author(s):

Pierpaolo Correale ◽

Stefania Marsili ◽

Marianna Sabatino ◽

Francesco Montagnani ◽

Giorgio Giorgi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Low Dose ◽

Interleukin 2 ◽

Macrophage Colony ◽

Phase II Study of Combination Thalidomide/Interleukin-2 Therapy Plus Granulocyte Macrophage-Colony Stimulating Factor in Patients With Metastatic Renal Cell Carcinoma

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31815e4505 ◽

2008 ◽

Vol 31 (3) ◽

pp. 237-243 ◽

Cited By ~ 15

Author(s):

Robert J. Amato ◽

Rahul Malya ◽

Anish Rawat

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Macrophage Colony ◽

Granulocyte-Macrophage Colony-Stimulating Factor, Interferon Alpha and Interleukin-2 as Adjuvant Treatment for High-Risk Renal Cell Carcinoma

Journal of Cancer Science & Therapy ◽

10.4172/1948-5956.1000042 ◽

2010 ◽

Vol 02 (06) ◽

Author(s):

Ilya Tsimafeyeu

Keyword(s):

Renal Cell Carcinoma ◽

High Risk ◽

Cell Carcinoma ◽

Adjuvant Treatment ◽

Renal Cell ◽

Interleukin 2 ◽

Macrophage Colony ◽

A Phase II Trial of Concomitant Interferon-α-2b and Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Advanced Renal Cell Carcinoma

Journal of Immunotherapy ◽

10.1097/00002371-199501000-00007 ◽

1995 ◽

Vol 17 (1) ◽

pp. 58-61 ◽

Cited By ~ 8

Author(s):

Robert T. OʼDonnell ◽

Gilland Dea ◽

Frederick J. Meyers

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Trial ◽

Interferon Α ◽

Macrophage Colony ◽

Phase II Study of thalidomide, Interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients with metastatic renal cell carcinoma (RCC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4702 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4702-4702 ◽

Cited By ~ 1

Author(s):

A. Rawat ◽

R. J. Amato

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Gm Csf ◽

Macrophage Colony ◽

A Phase Ib/II trial of granulocyte-macrophage?colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases

Cancer ◽

10.1002/(sici)1097-0142(20000415)88:8<1892::aid-cncr19>3.0.co;2-2 ◽

2000 ◽

Vol 88 (8) ◽

pp. 1892-1901 ◽

Cited By ~ 17

Author(s):

Kirsten M. Hotton ◽

Masoud Khorsand ◽

Jacquelyn A. Hank ◽

Mark Albertini ◽

Kyung Mann Kim ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Pulmonary Metastases ◽

Interleukin 2 ◽

Phase Ib ◽

Macrophage Colony ◽

Immune Effects of Escalating Doses of Granulocyte-Macrophage Colony-Stimulating Factor Added to a Fixed, Low-Dose, Inpatient Interleukin-2 Regimen: A Randomized Phase I Trial in Patients With Metastatic Melanoma and Renal Cell Carcinoma

Journal of Immunotherapy ◽

10.1097/00002371-200303000-00005 ◽

2003 ◽

Vol 26 (2) ◽

pp. 130-138 ◽

Cited By ~ 16

Author(s):

John W. Smith ◽

Robert A. Kurt ◽

Angelo G. Baher ◽

Susan Denman ◽

Lisa Justice ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Phase I ◽

Renal Cell ◽

Phase I Trial ◽

Low Dose ◽

Interleukin 2 ◽

Macrophage Colony ◽

Phase II Study of thalidomide, Interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients with metastatic renal cell carcinoma (RCC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4702 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4702-4702

Author(s):

A. Rawat ◽

R. J. Amato

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Gm Csf ◽

Macrophage Colony ◽

Phase II study of thalidomide, Interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients (pts) with metastatic renal cell carcinoma (MRCC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4717 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4717-4717

Author(s):

M. Morgan ◽

A. Rawat ◽

R. J. Amato

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Gm Csf ◽

Macrophage Colony ◽

271 Phase II Study of Thalidomide, interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients with metastatic renal cell carcinoma (RCC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80279-9 ◽

2004 ◽

Vol 2 (8) ◽

pp. 83 ◽

Cited By ~ 1

Author(s):

R. Amato ◽

J. Brown ◽

A. Rawat

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Gm Csf ◽

Macrophage Colony ◽